Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 11,870 |
| Receivables | 90 |
| Other current assets | 30 |
| TOTAL | $11,990 |
| Non-Current Assets | |
| PPE Net | 2,600 |
| TOTAL | $2,600 |
| Total Assets | $14,590 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 400 |
| TOTAL | $400 |
| Non-Current Liabilities | |
| Long Term Debt | 100 |
| Other Non-Current Liabilities | 660 |
| TOTAL | $760 |
| Total Liabilities | $1,170 |
| Shareholders' Equity | |
| Common Shares | 14,560 |
| Retained earnings | -2,820 |
| TOTAL | $13,420 |
| Total Liabilities And Equity | $14,590 |